Hüppa põhisisu juurde
Raamatukoi
Tõde ja õigus

Neurophysiologic Biomarkers in Neuropsychiatric Disorders

Etiologic and Treatment Considerations

Daniel C. Javitt, James C. McPartland (toim.) · Springer International Publishing AG · 2024

Neurophysiologic Biomarkers in Neuropsychiatric Disorders

This book reviews neurophysiological biomarkers in neuropsychiatric disorders from the viewpoint of the 21st Century Cures Act, which encourages the use of biomarkers for a variety of purposes during drug development. It covers both traditional etiologic uses of biomarkers and the more recent Biomarkers, EndpointS, and other Tools (BEST) classification scheme used by the FDA, which permits biomarkers for purposes of susceptibility, diagnosis, monitoring, prognosis, pharmacodynamics/response, and safety. The first section of the book describes potential uses of neurophysiologic biomarkers. Subsequent sections focus on a wide range of conditions, including schizophrenia, autism spectrum disorder, Parkinson's disease, and depression, as well as cross-diagnostic and translational uses, including monkey and rodent analogs. The purpose of the book is to help clinicians understand how neurophysiological biomarkers may be used to understand and manage clinical conditions; to help researchers to understand how biomarkers may be used translationally to test specific theories; and to help pharma investigators to understand how biomarkers can be used to accelerate treatment development.

Saadavus
284,00 €

Uus kasutamata raamat

Täna tellides on tarneaeg umbes 10 päeva (27.11.2026)Tellimuse täitmise aeg on umbkaudne ja sõltub nädalapäevast, millal tellimus tehakse. Reeglina ei kulu üle kahe nädala.

Tarne ja kättesaamine

Detailid

Alapealkiri
Etiologic and Treatment Considerations
Autorid
Daniel C. Javitt, James C. McPartland (toim.)
ISBN
9783031694905
Aasta
2024
Keel
inglise
Köide
Kõva kaas
Lehekülgi
831
Teema
Meditsiin › Kliiniline meditsiin ja sisehaigused — Clinical & internal medicine
Kaal
1.37 kg